Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetravalent Live Attenuated Dengue Vaccine in Children
NCT00384670Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Aug 2003
- Primary completion
- May 2004
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of T-DEN vaccine in dengue fever, sponsored by U.S. Army Medical Research and Development Command. Primary endpoint: Number of Solicited Adverse Events Within 21 Days After the First Dose of Dengue Vaccine. Started Aug 2003; status: completed.
02
Drugs
T-DEN vaccine
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT00384670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384670.